期刊文献+

影响经动脉子宫颈癌热灌注化疗临床疗效的多因素分析

Multiple Clinical Factors analysis for Transcatheter Arterial Hyperthermic Perfusion Chemotherapy of Uterine Cervical Cancer
原文传递
导出
摘要 目的:探讨宫颈癌热灌注化疗栓塞的治疗作用及对临床疗效的影响因素分析。方法:对34例宫颈癌病人进行子宫动脉热灌注化疗及栓塞术,分析肿瘤病理类型,肿块大小,周围浸润及淋巴结转移情况等因素对介入治疗的影响。结果:经过对临床疗效的多因素分析肿块大小对治疗效果影响最大,其次为病理类型。其余影响较小。结论:宫颈癌热灌注化疗栓塞术是治疗宫颈癌的一种适合疗法,尤其适用于肿块较小的病人。可以使疾病得到有效控制,增加手术机会。 Objective: To evaluate the effects of intra-arterial hyperthermic perfusion chemotherapy for uterine cervical cancer,and to analyze which factor influencing the response to the chemotherapy.Methods: Thirty-four patients with cervical cancer were enrolled in this study.Heating intra-arteray chemothyrapy was performed using cisplatin-based regimens.The response was assessed by ultra-sound and examination of surgical specimens.Results: Clinical response was achieved in 28(82%) patients.Twenty-eight of the 38 parametrial halves were free from cancer.No lymph node metastases were found in eight patients.Initial tumor volume was found to be an independent,significant determining factor of the response to the therapy.Pathological type is another fator which influnce the intervention therapy.Conclusion: Intra-atery hyperthermic perfusion chemotherapy for cervical cancer is useful for the tumor reduction.Tumor vol-ume is a significant determining factor for the response to intra-artery hyperthermic perfusion chemotherapy of uterine cervical cancer
出处 《现代生物医学进展》 CAS 2012年第16期3095-3097,共3页 Progress in Modern Biomedicine
关键词 宫颈癌 温热灌注化疗 栓塞 经动脉 Uterine cervical cancer Hyperthermic pefusion chemotherapy Embolision Transartery
  • 相关文献

参考文献20

  • 1Nagata Y,Araki N. Ncoadjuvant chemotherapy by transcatheter artrial infusion method for uterine cervical cancer[J].Journal of Vascular and Interventional Radiology,2000,(03):313-319.doi:10.1016/S1051-0443(07)61423-7.
  • 2Tsuda H,Tanaka M,Manabe T. Phase Ⅰ-Ⅱ study ofneoadjuvant chcmoradiothcrapy followcd by radical surgery inlocally advanced ccrvical cancer[J].Anti-Cancer Drug Design,2001,(10):853-858.doi:10.1097/00001813-200111000-00010.
  • 3Kuzuya K. Chemoradiotherapy for uterine cancer:current status andperspectives[J].Int J Clinical,2004,(06):458-470.
  • 4Nagata Y,Araki N,Kinura H. Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer[J].Journal of Vascular and Interventional Radiology,2000,(3):313-319.doi:10.1016/S1051-0443(07)61423-7.
  • 5Yamakawa Y,Fujimura M,Hidaka T. Neoadjuvant intraarterial infusion chemotherapy in patients with stage ⅡB2-ⅢB cervical cancer[J].Gynecologic Oncology,2000.264-270.doi:10.1006/gyno.2000.5730.
  • 6Symonds P. Chemoradiation:the new gold standard for non-surgical treatment of cervical cancer[J].Clin Oncol Coll Radiol,2002,(03):201-202.doi:10.1111/j.1471-4159.2009.06279.x.
  • 7Benedetti-Panici PL,Zullo MA,Muzii L. The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer[J].European Journal of Gynaecological Oncology,2003,(06):467-470.
  • 8Itoh N,Sawairi M,Hanabayashi T. Neoadjuvant intraarterial infusion chemotherapy with a combination of mitomycin-C,vincristine,and cisplatin for locally advanced cervical cancer:apreliminary report[J].Gynecologic Oncology,1992,(03):391-394.doi:10.1016/0090-8258(92)90146-A.
  • 9Tsuda H,Tanaka M,Manabe T. Phase Ⅰ-Ⅱ study of neoadjuvant chemoradiotherapy followed by radical surgery inlocally advanced cervical cancer[J].Anti-Cancer Drug Design,2002,(10):853-858.
  • 10Frei EILL. Clinical and scientific considerations in preoperative (neoadjuvant) chemotherapy[J].Resent Results in Cancer Research,1986,(13):1-5.doi:10.1016/j.bmcl.2009.04.119.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部